ALTIMMUNE, INC. Total Long-Term Debt
ALTIMMUNE, INC. (ALT) had Total Long-Term Debt of $34.74 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2026-08-12
- 2019-06-30: Long-term Debt 500.00K EUR.
- 2019-03-31: Long-term Debt 500.00K EUR.
- 2018-12-31: Long-term Debt 500.00K EUR.
- 2017-12-31: Long-term Debt 500.00K EUR.
EUR
| Period end | Long-term Debt |
|---|---|
| 2019-06-30 | 500.00K EUR 10-Q · filed 2019-08-13 |
| 2019-03-31 | 500.00K EUR 10-Q · filed 2019-05-14 |
| 2018-12-31 | 500.00K EUR 10-K · filed 2019-04-01 |
| 2017-12-31 | 500.00K EUR 10-K · filed 2019-04-01 |
USD
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $34.74M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $34.51M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $34.29M 10-Q · filed 2026-08-12 |
| 2019-06-30 | $568.32K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $561.58K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $572.77K 10-K · filed 2019-04-01 |
| 2017-12-31 | $599.93K 10-K · filed 2019-04-01 |
| 2017-09-30 | $590.18K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $570.54K 10-Q · filed 2017-08-14 |
| 2016-12-31 | $525.95K 10-Q · filed 2017-11-09 |
| 2014-09-30 | $993.32K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $1.24M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $1.49M 10-Q · filed 2014-05-08 |
| 2013-09-30 | $2.00M 10-Q · filed 2013-11-07 |
| 2012-09-30 | $2.50M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $2.50M 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |